← Open Payments lookup

SHEMILA FASIHI: Open Payments

NPI 1033952627 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$245 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $234 · 2025 $245

Food & beverage: $245
CompanyPaymentsAmount
Alexion Pharmaceuticals, Inc.1$106
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$49
Veloxis Pharmaceuticals, Inc.1$38
Ethicon US, LLC1$28
Intercept Pharmaceuticals, Inc.1$25

Products named: ULTOMIRIS, XIFAXAN, ENVARSUS, PROLENE, OCALIVA.

Industry payments across DC — which companies pay providers there.